In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.

Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.

Senior Correspondent Later this year, a handful of people with a rare eye condition will receive a novel injection that is designed to quite literally turn back time. Nonarteritic anterior ischemic ...